Verified source brief
STAT+: Pharmalittle: We’re reading about an FDA gender rule change, its program for one-day inspections, and more
An FDA proposal to remove references to “gender” from its regulations sparked concerns about unintended consequences on research
Source brief
An FDA proposal to remove references to “gender” from its regulations sparked concerns about unintended consequences on research
Original source
This is a source-linked brief from STAT. Read the original item at STAT+: Pharmalittle: We’re reading about an FDA gender rule change, its program for one-day inspections, and more.
Attribution
VINI publishes the headline, source metadata, short feed summary, topic labels, and outbound source link for reader discovery. The full article remains with the original publisher.
- Published by source: 2026-05-08T13:17:39+00:00
This source-linked brief summarizes publisher-provided metadata and links to the original report. VINI does not republish third-party article bodies without rights clearance. 1 source listed.
Source links
- STAT+: Pharmalittle: We’re reading about an FDA gender rule change, its program for one-day inspections, and moreSTAT - 2026-05-08T13:17:39+00:00
Reader comments
Moderated discussion
Comments are open to authenticated approved accounts, screened for spam and abuse, and published only after newsroom moderation unless editors change the story control.